|

Azacitidine (AZA) Days 1 - 5 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION1
  • Relapse1
  • T-cell Acute Lymphoblastic Leukemia1
  • Cancer1

Other1 trial

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.